UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
Status:
Completed
Trial end date:
2019-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the clinical efficacy of MV-NIS (measles
virus-sodium iodide symporter) therapy for people with relapsed/refractory myeloma when given
with cyclophosphamide